Macquarie Group
GEVA

Macquarie Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Macquarie Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
2015
Q1 		$5.91M Buy
2014
Q4 		$4.73M Hold
2014
Q3 		$3.51M Buy
2014
Q2 		$3.94M Hold
2014
Q1 		$3.12M Sell
2013
Q4 		$2.52M Hold
2013
Q3 		$2.46M Buy
2013
Q2 		$1.26M Buy